Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 1,039 | 4,013 | 4,737 | 1,078 | 71 |
| Gross Profit | 1,039 | 4,013 | 4,737 | 1,078 | 71 |
| Operating Expenses | 339,893 | 226,621 | 172,619 | 108,780 | 75,024 |
| Operating Income | -338,854 | -222,608 | -167,882 | -107,702 | -74,953 |
| Other Income | 40,446 | 8,079 | 3,964 | 61 | 1,141 |
| Pre-tax Income | -298,408 | -214,529 | -163,918 | -107,641 | -73,812 |
| Net Income Continuous | -298,408 | -214,529 | -163,918 | -107,641 | -73,812 |
| Net Income | $-298,408 | $-214,529 | $-163,918 | $-107,641 | $-73,812 |
| EPS Basic Total Ops | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 |
| EPS Basic Continuous Ops | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 |
| EPS Diluted Total Ops | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 |
| EPS Diluted Continuous Ops | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 |
| EPS Diluted Before Non-Recurring Items | -3.69 | -3.69 | -3.15 | -2.80 | -2.42 |
| EBITDA(a) | $-351,000 | $-227,781 | $-166,865 | $-106,358 | $-74,232 |